Daily non-political popular news in brief.
Temple University Hospital investigates new prophylactic HPV vaccine
01-30-2007 · EurekAlert!Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
Read more »
Keywords: temple, university, hospital, investigates, prophylactic, hpv, vaccine, investigate
« Previous | Next »
Similar news on "Temple University Hospital investigates new prophylactic HPV vaccine":
- Temple University Hospital investigates treatment for cervical dysplasia
01-30-2007 · EurekAlert!
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
Similar news · Read more »
- Music Helps Patients Tune Out Test Anxiety During Colonoscopy Procedure
09-29-2006 · ScienceDaily
Patients who plug into their favorite tunes during a colonoscopy procedure may be able to relax enough to require less sedation, without sacrificing comfort, according to a new study by doctors at Temple University School of Medicine and Hospital in Philadelphia.
Similar news · Read more »
- International studies show high efficacy for HPV vaccine
05-31-2007 · EurekAlert!
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancerÑstrains 16 and 18. Researchers combined and analyzed the data from four randomized trials that involved 20,583 women ages 15 to 26 from more than two dozen countries. Researchers found that the prophylactic administration of the vaccine was highly effective in preventing pre-malignant changes of the cervix.
Similar news · Read more »
- Vaccine can help reduce frequent ear infections in children, research shows
04-02-2007 · EurekAlert!
A vaccine has been shown to help reduce the number of infants and toddlers developing frequent ear infections, according to new research from Katherine A. Poehling, M.D., a pediatrician at Brenner Children’s Hospital, part of Wake Forest University Baptist Medical Center. Results from her study are published in the April issue of Pediatrics.
Similar news · Read more »
- Novel genetics research advances possibility of HIV vaccine
07-05-2007 · EurekAlert!
A pioneering collaborative study has discovered how the HIV virus evades the human body's immune system. The research collaborative -- involving scientists from the British Columbia Centre for Excellence in HIV/AIDS, Massachusetts General Hospital, Microsoft Research and Los Alamos National Laboratory -- used highly computer-intensive, cutting-edge statistical research methods to investigate how the HIV virus mutates to escape the body's immune system.
Similar news · Read more »
- Painkillers may threaten power of vaccines
11-28-2006 · EurekAlert!
With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea.
Similar news · Read more »
- A missed shot: The failure of HPV vaccination state requirements
11-01-2007 · EurekAlert!
In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus vaccine debate, and its effects on ethical and public health issues.
Similar news · Read more »
- MRSA vaccine shows promise in mouse study
10-30-2006 · EurekAlert!
By combining the four bacterial surface proteins that generate the strongest immune response in mice, researchers at the University of Chicago have created a vaccine that significantly protects immunized animals from multiple disease-causing, drug-resistant strains of Staphylococcus aureus, the most common cause of hospital-acquired infections and a rapidly spreading source of community-associated illness.
Similar news · Read more »
- Measuring pandemic preparedness
11-29-2006 · EurekAlert!
The federal plan to vaccinate hospital health-care workers against a threat of smallpox fell short on several levels according to a new Temple University study. It raises troubling questions about future preparedness against possible outbreaks of avian flu or SARS.
Similar news · Read more »
- Nursing home or hospital: State policy has big impact on elderly
12-13-2006 · EurekAlert!
In a groundbreaking national study, Brown University researchers have traced the connections between state nursing home policies and resident hospitalization rates. The team found that state policies unwittingly create financial incentives for nursing homes to hospitalize their frail elderly residents, even though hospital stays can be disorienting or dangerous. Results are published in Health Services Research.
Similar news · Read more »
